Publication date: Oct 30, 2024
China is ranked third globally in terms of burden and has a moderately high to high prevalence of tuberculosis (TB). This study meticulously investigated the notification rates of TB and assessed the epidemic in China from 2000 to 2021. The aim of the study was to provide robust supporting data that is crucial for enhancing TB prevention and control strategies. Extensive data regarding TB notification rates in China between 2000 and 2021 was collected. The joinpoint regression model was subsequently utilized to assess the temporal trends in the notification rates of TB, which were analyzed through the annual percentage change (APC) and the average annual percentage change (AAPC). During the study period (2000-2021), the standardized notification rates of TB in China ranged from 38. 89/100,000 to 101. 15/100,000, with a significant annual average decrease of 4. 43% (P
Open Access PDF
Semantics
| Type | Source | Name |
|---|---|---|
| disease | MESH | Tuberculosis |
| pathway | KEGG | Tuberculosis |
| pathway | REACTOME | Reproduction |
| disease | MESH | Infectious Diseases |
| drug | DRUGBANK | Coenzyme M |
| disease | MESH | Tumor |
| disease | MESH | COVID 19 pandemic |
| disease | IDO | susceptibility |
| drug | DRUGBANK | Indoleacetic acid |
| drug | DRUGBANK | Dapsone |